삼성서울병원

Ko En

Pathology Choi, Yoon La M.D

Expertise
Molecular Pathology, Bone & soft tissue Pathology
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Seoul National University Hospital
Samsung Medical Center
Residency   Samsung Medical Center
Internship   Seoul National University Hospital

Professional Appointments

Stanford University, Department of Pathology, Visiting Instructor

Professional Memberships

· A member of Korean Pathology Society
· A member of Korean Breast Cancer Society
· A member of United States and Canadian Academy of Pathology
· A member of American Association for Cancer Research

Selected Publications

  • CANCER 2021 10.1002/cncr.33571 High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program Park1, S; Olsen, S; Ku, BM; Lee, MS; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.434 TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis Jung1, K; Choi, JS; Koo, BM; Kim, YJ; Song, JY; Sung, M; Chang, ES; Noh, KW; An, S; Lee, MS; Song, K; Lee, H; Kim, RN; Shin, YK; Oh, DY; Choi, YL
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status Lee1, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13648 Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma A single-institute experience of 10 cases Cho1, YA; Choi, YL; Hwang, I; Lee, K; Cho, JH; Han, J
    View PubMed